Preloader

Personalized phosphoproteomics identifies functional signaling

  • 1.

    Humphrey, S. J., James, D. E. & Mann, M. Protein phosphorylation: a major switch mechanism for metabolic regulation. Trends Endocrinol. Metab. 26, 676–687 (2015).

    CAS 
    PubMed 

    Google Scholar 

  • 2.

    Humphrey, S. J. et al. Dynamic adipocyte phosphoproteome reveals that Akt directly regulates mTORC2. Cell Metab. 17, 1009–1020 (2013).

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • 3.

    Lundby, A. et al. Oncogenic mutations rewire signaling pathways by switching protein recruitment to phosphotyrosine sites. Cell 179, 543–560 (2019).

    CAS 
    PubMed 

    Google Scholar 

  • 4.

    Robles, M. S., Humphrey, S. J. & Mann, M. Phosphorylation is a central mechanism for circadian control of metabolism and physiology. Cell Metab. 25, 118–127 (2017).

    CAS 
    PubMed 

    Google Scholar 

  • 5.

    Bodenmiller, B. et al. Phosphoproteomic analysis reveals interconnected system-wide responses to perturbations of kinases and phosphatases in yeast. Sci. Signal. 3, rs4 (2010).

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • 6.

    Needham, E. J., Parker, B. L., Burykin, T., James, D. E. & Humphrey, S. J. Illuminating the dark phosphoproteome. Sci. Signal. 12, eaau8645 (2019).

    CAS 
    PubMed 

    Google Scholar 

  • 7.

    Oliveira, A. P. et al. Regulation of yeast central metabolism by enzyme phosphorylation. Mol. Syst. Biol. 8, 623 (2012).

    PubMed 
    PubMed Central 

    Google Scholar 

  • 8.

    Gonçalves, E. et al. Systematic analysis of transcriptional and post-transcriptional regulation of metabolism in yeast. PLoS Comput. Biol. 13, e1005297 (2017).

    PubMed 
    PubMed Central 

    Google Scholar 

  • 9.

    Ochoa, D. et al. The functional landscape of the human phosphoproteome. Nat. Biotechnol. 38, 365–373 (2020).

    CAS 
    PubMed 

    Google Scholar 

  • 10.

    Hoffman, N. J. et al. Global phosphoproteomic analysis of human skeletal muscle reveals a network of exercise-regulated kinases and AMPK substrates. Cell Metab. 22, 922–935 (2015).

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • 11.

    Hingst, J. R. et al. Exercise-induced molecular mechanisms promoting glycogen supercompensation in human skeletal muscle. Mol. Metab. 16, 24–34 (2018).

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • 12.

    Humphrey, S. J., Azimifar, S. B. & Mann, M. High-throughput phosphoproteomics reveals in vivo insulin signaling dynamics. Nat. Biotechnol. 33, 990–995 (2015).

    CAS 
    PubMed 

    Google Scholar 

  • 13.

    Humphrey, S. J., Karayel, O., James, D. E. & Mann, M. High-throughput and high-sensitivity phosphoproteomics with the EasyPhos platform. Nat. Protoc. 13, 1897–1916 (2018).

    CAS 
    PubMed 

    Google Scholar 

  • 14.

    Liu, J. J. et al. In vivo brain GPCR signaling elucidated by phosphoproteomics. Science 360, eaao4927 (2018).

    PubMed 
    PubMed Central 

    Google Scholar 

  • 15.

    Hojlund, K. et al. Human ATP synthase beta is phosphorylated at multiple sites and shows abnormal phosphorylation at specific sites in insulin-resistant muscle. Diabetologia 53, 541–551 (2010).

    CAS 
    PubMed 

    Google Scholar 

  • 16.

    Batista, T. M. et al. A cell-autonomous signature of dysregulated protein phosphorylation underlies muscle insulin resistance in type 2 diabetes. Cell Metab. 32, 844–859 (2020).

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • 17.

    Vaag, A., Henriksen, J. E. & Beck-Nielsen, H. Decreased insulin activation of glycogen synthase in skeletal muscles in young nonobese Caucasian first-degree relatives of patients with non-insulin-dependent diabetes mellitus. J. Clin. Invest. 89, 782–788 (1992).

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • 18.

    Um, S. H. et al. Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity. Nature 431, 200–205 (2004).

    CAS 
    PubMed 

    Google Scholar 

  • 19.

    Carraro, F., Stuart, C. A., Hartl, W. H., Rosenblatt, J. & Wolfe, R. R. Effect of exercise and recovery on muscle protein synthesis in human subjects. Am. J. Physiol. 259, E470–E476 (1990).

    CAS 
    PubMed 

    Google Scholar 

  • 20.

    Krycer, J. R. et al. Dynamic metabolomics reveals that insulin primes the adipocyte for glucose metabolism. Cell Rep. 21, 3536–3547 (2017).

    CAS 
    PubMed 

    Google Scholar 

  • 21.

    Phan, J. & Reue, K. Lipin, a lipodystrophy and obesity gene. Cell Metab. 1, 73–83 (2005).

    CAS 
    PubMed 

    Google Scholar 

  • 22.

    Hardie, D. G., Ross, F. A. & Hawley, S. A. AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nat. Rev. Mol. Cell Biol. 13, 251–262 (2012).

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • 23.

    Kjøbsted, R. et al. Enhanced muscle insulin sensitivity after contraction/exercise is mediated by AMPK. Diabetes 66, 598–612 (2017).

    PubMed 

    Google Scholar 

  • 24.

    Lopez-Mejia, I. C. et al. CDK4 phosphorylates AMPKalpha2 to inhibit its activity and repress fatty acid oxidation. Mol. Cell 68, 336–349.e6 (2017).

    CAS 
    PubMed 

    Google Scholar 

  • 25.

    Rodrik-Outmezguine, V. S. et al. Overcoming mTOR resistance mutations with a new-generation mTOR inhibitor. Nature 534, 272–276 (2016).

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • 26.

    Ling, N. X. Y. et al. mTORC1 directly inhibits AMPK to promote cell proliferation under nutrient stress. Nat. Metab. 2, 41–49 (2020).

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • 27.

    Inoki, K., Zhu, T. & Guan, K.-L. TSC2 mediates cellular energy response to control cell growth and survival. Cell 115, 577–590 (2003).

    CAS 
    PubMed 

    Google Scholar 

  • 28.

    Gwinn, D. M. et al. AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol. Cell 30, 214–226 (2008).

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • 29.

    Mertins, P. et al. Proteogenomics connects somatic mutations to signalling in breast cancer. Nature 534, 55–62 (2016).

    PubMed 
    PubMed Central 

    Google Scholar 

  • 30.

    Gillette, M. A. et al. Proteogenomic characterization reveals therapeutic vulnerabilities in lung adenocarcinoma. Cell 182, 200–225 (2020).

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • 31.

    Wojtaszewski, J. F., Hansen, B. F., Kiens, B. & Richter, E. A. Insulin signaling in human skeletal muscle: time course and effect of exercise. Diabetes 46, 1775–1781 (1997).

    CAS 
    PubMed 

    Google Scholar 

  • 32.

    Ong, S.-E. et al. Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol. Cell. Proteomics 1, 376–386 (2002).

    CAS 
    PubMed 

    Google Scholar 

  • 33.

    Cox, J. et al. Accurate proteome-wide label-free quantification by delayed normalization and maximal peptide ratio extraction, termed MaxLFQ. Mol. Cell. Proteomics 13, 2513–2526 (2014).

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • 34.

    Cox, J. & Mann, M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat. Biotechnol. 26, 1367–1372 (2008).

    CAS 
    PubMed 

    Google Scholar 

  • 35.

    Tyanova, S. et al. The Perseus computational platform for comprehensive analysis of (prote)omics data. Nat. Methods 13, 731–740 (2016).

    CAS 
    PubMed 

    Google Scholar 

  • 36.

    Bekker-Jensen, D. B. et al. Rapid and site-specific deep phosphoproteome profiling by data-independent acquisition without the need for spectral libraries. Nat. Commun. 11, 787 (2020).

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • 37.

    Yang, P. et al. Multi-omic profiling reveals dynamics of the phased progression of pluripotency. Cell Syst. 8, 427–445 (2019).

  • 38.

    Needham, E. J. et al. Phosphoproteomics of acute cell stressors targeting exercise signaling networks reveal drug interactions regulating protein secretion. Cell Rep. 29, 1524–1538 (2019).

    CAS 
    PubMed 

    Google Scholar 

  • 39.

    Ritchie, M. E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43, e47 (2015).

    PubMed 
    PubMed Central 

    Google Scholar 

  • 40.

    Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. Series B Stat. Methodol. 57, 289–300 (1995).

    Google Scholar 

  • 41.

    Conway, J. R., Lex, A. & Gehlenborg, N. UpSetR: an R package for the visualization of intersecting sets and their properties. Bioinformatics 33, 2938–2940 (2017).

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • 42.

    Storey, J., Bass, A., Dabney, A., Robinson, D. & Warnes, G. qvalue: Q-value estimation for false discovery rate control. https://www.bioconductor.org/packages/devel/bioc/manuals/qvalue/man/qvalue.pdf (2021).

  • 43.

    Hornbeck, P. V. et al. PhosphoSitePlus, 2014: mutations, PTMs and recalibrations. Nucleic Acids Res. 43, D512–D520 (2015).

    CAS 
    PubMed 

    Google Scholar 

  • 44.

    Ochoa, D. et al. An atlas of human kinase regulation. Mol. Syst. Biol. 12, 888 (2016).

    PubMed 
    PubMed Central 

    Google Scholar 

  • 45.

    Chen, J. et al. The trans-ancestral genomic architecture of glycemic traits. Nat. Genet. 53, 840–860 (2021).

    CAS 
    PubMed 

    Google Scholar 

  • 46.

    Dickinson, M. E. et al. High-throughput discovery of novel developmental phenotypes. Nature 537, 508–514 (2016).

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Source link